Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2021
(2)
2020
(3)
2019
(1)
Decision
Transfer
(4)
Cancellation
(2)
Complainant
Sanofi
(4)
Sanofi Biotechnology
(1)
Genzyme Corporation
(1)
Asendia Management
(1)
Respondent
Domain Administrator, See PrivacyGuardian.org / Home of Domains, Domain Admin / This Domain is For Sale
(1)
Domain Admin, Privacy Protect, LLC (PrivacyProtect.org) / Yabani Eze, Sugarcane Internet Nigeria Limited
(1)
Domain Admin, Privacy Protect, LLC (PrivacyProtect.org) / Wes Martz
(1)
Domain Admin, Privacy Protect, LLC (PrivacyProtect.org) / Jide Amoo
(1)
Domain Admin, Privacy Protect, LLC (PrivacyProtect.org) / Genzyme Pharm
(1)
Domain Admin / Privacy Protect, LLC, Martin Anthony Santiago
(1)
Panelist
Phillip V. Marano
(1)
Petra Pecar
(1)
M. Scott Donahey
(1)
Kar Liang Soh
(1)
Clive N.A. Trotman
(1)
Assen Alexiev
(1)
Complainant Country
France
(6)
Complainant Representative
Marchais
(6)
Respondent Country
United States
(6)
Respondent Reply
Yes
(3)
No
(3)
RDNH Status
No
(6)
Case Language
English
(6)
Case Particular
D
(6)
Number Of Domains
1
(5)
2
(1)
Domain Extension
com
(6)
Domain Extension Type
gTLD
(6)
Domain Length
9
(1)
15
(2)
17
(1)
20
(1)
22
(1)
23
(1)
Includes Hyphen
Yes
(1)
No
(5)
Includes Number
No
(6)
Includes Letter
Yes
(6)
Domain Registrar
PDR Ltd. d/b/a PublicDomainRegistry.com
(3)
Shinjiru MSC Sdn Bhd
(1)
NameSilo, LLC
(1)
6
cases found.
Complainant Representative: Marchais
Respondent Country: United States
Respondent: Domain Admin
Reset Search
genzymepharminc.com
Transfer
WIPO D2020-3072
(Decision Date: Jan. 20, 2021)
sanoficlinicalresearch.com, sanoficlinicaltrials.com
Cancellation
WIPO D2020-2624
(Decision Date: Feb. 12, 2021)
ambien-medication.com
Transfer
WIPO D2020-1780
(Decision Date: Oct. 7, 2020)
sanofipatientconnectiom.com
Cancellation
WIPO D2020-1779
(Decision Date: Aug. 21, 2020)
asendiads.com
Transfer
WIPO D2020-0489
(Decision Date: May 11, 2020)
libtayosurround.com
Transfer
WIPO D2018-2420
(Decision Date: Jan. 22, 2019)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll